The chief executive officer of Debiopharm's corporate subsidiary will be replaced by Marc Cikes in early June
Tanja Dowe has announced her departure from Debiopharm Innovation Fund, the corporate fund of the Switzerland-based biopharmaceuticals corporation, Debiopharm.
After serving more than five years as the fund’s chief executive officer, Dowe will be replaced by Marc Cikes who will take over the role on June 1st.
“I will be moving on to pursue new steps in my career,” says Dowe, “It has been…
